E-PaperReddys Lab News
Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — February 26
Buy or sell stocks: Sumeet Bagadia has recommended three stocks to buy on Monday — Dr Reddy's Laboratories, M&M, and Reliance
4 min read26 Feb 2024Dr Reddys Laboratories Q3 FY24 Results Live : profit rise by 11.01% YOY
Dr Reddys Laboratories Q3 FY24 Results Live : Revenue increased by 6.58% YoY & profit increased by 11.01% YoY
1 min read1 Feb 2024Pharma Outlook 2024: How are Cipla, Sun Pharma, Dr Reddy's and others likely to perform this year?
Pharma companies – Cipla, Torrent Pharma, Eris Lifesciences, and JB Chemicals, among others – have increased their chronic presence, focused on new product launches, and entered into new therapies.
3 min read1 Jan 2024Buy or sell: Sumeet Bagadia recommends three stocks to buy next week
Buy or sell stocks: Sumeet Bagadia has recommended three stocks to buy on Monday — Asian Paints, Dr Reddy's Laboratories and Grasim Industries
4 min read18 Nov 2023Nerivio: From price to efficacy, all you need to know about drug-free migraine treatment
Dr Reddy's Laboratories introduced Nerivio, a wearable therapy device for migraine management. It has shown effectiveness in relieving pain and reducing the need for acute treatment drugs in nine out of 10 patients, the drug maker said.
3 min read18 Nov 2023Buy or sell: Sumeet Bagadia recommends three stocks to buy this week
Buy or sell stocks: Sumeet Bagadia has recommended three stocks to buy on Tuesday — Hero MotoCorp, Dr Reddy's and Metro Brands
4 min read2 Oct 2023Cipla, Sun Pharma among top pharma picks for Motilal Oswal as US sales to help boost growth
Motilal Oswal upgrades Cipla's rating to 'Buy', while Dr Reddy's, Zydus Lifesciences, Lupin, Aurobindo Pharma, and Torrent Pharma maintain their ratings. Sun Pharma retains 'Buy' rating.
3 min read20 Sep 2023Dr Reddy share price hits 52-week high on strong Q1 results, but brokerages have mixed view; here's why
Dr Reddy's share price reached a 52-week high after the company reported strong Q1 results. Brokerages have mixed views with Nuvama Equities recommending a ‘reduce’ rating and Motilal Oswal maintaining a 'neutral' stance.
3 min read27 Jul 2023Stocks to trade ex-dividend from July 10-14; LTIMindtree, Titan, M&M, Dr Reddy's, Lupin, Bosch; do you own any?
A total of 55 stocks are scheduled to trade ex-dividend from July 10th to 14th, including big names like Lupin, Dr Reddy's, M&M, and Titan Company. Investors looking for dividend payouts should take note of these important dates.
5 min read9 Jul 2023Dr Reddy's Q4FY23 results miss street's estimates; should you still own the stock?
Dr Reddy's Q4FY23 results: The drugmaker's net profit for the quarter increased ten-fold, from ₹87.5 to ₹959.2 crore, but it still fell short of the street's forecast of ₹1,093.6 crore. Brokerages have expressed concern about the company's projected growth.
3 min read11 May 2023Popular Topics
Budget
The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared